Equities

Nuwellis Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NUWE:NAQ

Nuwellis Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.97
  • Today's Change-0.150 / -7.08%
  • Shares traded85.50k
  • 1 Year change-96.39%
  • Beta-0.0340
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

  • Revenue in USD (TTM)8.17m
  • Net income in USD-16.56m
  • Incorporated2002
  • Employees38.00
  • Location
    Nuwellis Inc12988 Valley View RdEDEN PRAIRIE 55344-3657United StatesUSA
  • Phone+1 (952) 345-4200
  • Fax+1 (302) 636-5454
  • Websitehttps://www.nuwellis.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
NUWE:NAQ since
announced
Transaction
value
Rendiatech LtdAnnounced19 Aug 202519 Aug 2025Announced-68.73%--
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Catheter Precision Inc730.00k-22.19m2.39m22.00--0.3473--3.27-37.38-37.380.93714.120.0281.646.3533,181.82-66.93-128.03-78.29-160.1292.60-242.70-2,393.84-15,268.880.4569-66.840.0449---4.98-19.8969.45---24.21--
Profusa Inc0.00-39.09m2.48m0.00---------278.73-278.730.00-61.050.00-------599.88-----------------14.56---------849.77------
INVO Fertility Inc6.94m-27.13m2.53m28.00------0.3644-602.89-644.6750.028.630.387419.5026.14247,996.40-149.96-63.14-299.48-98.9639.1760.46-387.11-276.300.1022-10.360.2530--116.2534.57-16.33--9.88--
Aethlon Medical Inc0.00-11.26m2.58m9.00--0.2597-----56.69-56.690.007.550.00----0.00-139.25-86.44-181.09-98.06-------3,662.04----0.00-------9.67------
Work Medical Technology Group Ltd9.85m-1.07m2.62m238.00--0.0071--0.2662-241.35-241.353,396.11214.42------41,381.18--1.52--4.5623.8122.30-12.192.521.50-7.760.23190.00-14.41-28.4569.28---39.54--
Fuse Medical Inc18.40m3.63m2.96m31.001.11--0.80140.16060.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
ENvue Medical Inc2.69m-5.21m3.08m15.00--0.0674--1.15-83.93-83.937.4642.000.09090.83646.45179,000.00-25.01-97.63-32.90-149.1830.0253.04-275.12-397.830.6675--0.0669--12.0537.000.1617------
Encision Inc6.30m-380.94k3.19m22.00--1.71--0.5064-0.0284-0.02840.50570.11051.662.277.98286,353.60-10.05-3.17-14.19-4.4052.6451.47-6.05-2.010.9127-5.690.1094---0.464-3.0968.17--8.09--
Vycor Medical Inc1.90m-338.88k3.67m7.00------1.93-0.0103-0.01030.0548-0.12061.891.576.73271,678.60-1.44-36.90----85.3589.43-0.7625-26.120.10280.8609----8.812.67-11.32---40.90--
Nuwellis Inc8.17m-16.56m3.69m38.00--0.6881--0.452-107.66-107.6626.642.871.111.656.71214,947.40-225.22-87.78-390.32-108.5359.0757.73-202.83-195.831.42-1.050.00---1.409.6653.05---34.30--
Avalon Globocare Corp1.40m-18.76m3.74m5.00------2.68-9.75-9.750.6074-1.100.0974--16.92279,216.00-131.94-76.04-1,379.37-114.3725.7023.19-1,355.20-888.890.1477-4.072.69--6.19-2.9252.69------
Axim Biotechnologies Inc92.90k-4.14m3.97m6.00------42.78-0.0163-0.01630.0003-0.03240.0233----15,483.33-103.73-154.34---390.7316.94---4,451.97-36,362.71---3.14----345.05-27.38-29.10------
Reflect Scientific Inc1.72m-29.42k4.04m7.00--1.9421.592.34-0.0004-0.00040.02010.02430.68260.84298.78245,945.70-1.1711.10-1.3213.2158.4762.48-1.7110.009.46--0.00---47.09-6.99-613.46------
Autonomix Medical Inc0.00-16.69m4.37m8.00--0.3684-----5.08-5.080.001.040.00----0.00-250.94---316.15--------------0.00------26.03------
bioAffinity Technologies Inc6.78m-14.74m4.68m57.00--0.4050--0.6904-20.74-20.749.342.570.7489161.377.97118,890.20-162.88---222.52--27.86---217.50--3.64-2.690.0332--269.68---13.89------
Data as of Feb 13 2026. Currency figures normalised to Nuwellis Inc's reporting currency: US Dollar USD

Institutional shareholders

7.20%Per cent of shares held by top holders
HolderShares% Held
Sabby Management LLCas of 31 Dec 202589.69k5.41%
DRW Securities LLCas of 31 Dec 202517.66k1.07%
Geode Capital Management LLCas of 31 Dec 202510.36k0.63%
Tower Research Capital LLCas of 30 Sep 20251.03k0.06%
UBS Securities LLCas of 31 Dec 2025578.000.04%
SBI Securities Co., Ltd.as of 31 Dec 202563.000.00%
Bank of America, NA (Private Banking)as of 30 Sep 20255.000.00%
Citigroup Global Markets, Inc. (Investment Management)as of 31 Dec 20253.000.00%
Ankerstar Wealth LLCas of 31 Dec 20251.000.00%
Two Sigma Securities LLCas of 30 Sep 20250.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.